P-rpl39e (9-18)[A15K, A16I]

General Information


DRACP ID  DRACP03882

Peptide Name   P-rpl39e (9-18)[A15K, A16I]

Sequence  KKLRLKIAFK

Sequence Length  10

UniProt ID  Q8ZTX6 

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C60H109N17O11

Absent amino acids  CDEGHMNPQSTVWY

Common amino acids  K

Mass  140535

Pl  12

Basic residues  5

Acidic residues  0

Hydrophobic residues  5

Net charge  5

Boman Index  -1757

Hydrophobicity  -34

Aliphatic Index  127

Half Life 
  Mammalian: 1 hour
  Yeast: 2 min
  E.coli: 2 min

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  0

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 31016969

Title  Short Cationic Peptide Derived from Archaea with Dual Antibacterial Properties and Anti-Infective Potential

Doi Not available

Year  2019

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  13929

DRACP is developed by Dr.Zheng's team.